Co-Founder & CEO
ParaNano Wound Care
OKC, OK
Chelsea Larsen, MBA, is CEO and Co-founder of ParaNano, LLC, and its subsidiaries ParaNano Wound Care, LLC and ParaNanoLabs, LLC.; She is responsible for contract management, regulatory strategy, and operations of the companies. Ms. Larsen began conducting research surrounding a novel Wound Care product technology in 2018, fully immersing herself in the world of wound care from a new product development perspective. She serves as the Entrepreneurial Lead under the NSF I-Corp Grant awarded to the University of Central Oklahoma in Fall 2020, Award Number (FAIN): 2053053. Through this, Ms. Larsen conducted over 200 interviews with those in the wound care space to find out what the true pain points of the industry are when it comes to diagnostic products and wound treatments. With this information, she received funding to develop the ParaNano Wound Care product, The Nanosheetâ„¢ Biosensor: a bioactive nanofiber membrane that detects bacterial infection and changes color when infection in a wound is detected above a critical threshold. The Nanosheetâ„¢ Biosensor achieved feasibility with this funding, and the final design is being identified and tested. This product encapsulates feedback from the providers in the industry, coupled with patented nanofiber technology developed at the University of Manitoba and the University of Central Oklahoma. Ms. Larsen is dedicated to the growth of ParaNano Wound Care and its products. She is leading her team and positioning her company as a top industry player, bringing innovative and essential wound care products to market that will change and help establish the standard of care.
Ms. Larsen is best known for her strong business sense and proven skills in new product development, business development and growth, customer discovery, and project management. She has co-founded three companies, each with license agreements to technology from institutions including the University of Central Oklahoma, the University of Manitoba, and NASA. Ms. Larsen has solicited and established relationships with bioscience industry players, including Impact Medical, AliraHealth, The SerenaGroup, Medline, Sanitis, & DSM. She has developed numerous animal model proposals directed towards FDA clearance and worked closely with FDA consultants to develop regulatory strategies. She has also built a team of experts in the wound care and biomedical space and has created a product development team and government agency experts.
Disclosure information not submitted.
Saturday, April 9, 2022
9:15 AM – 10:15 AM MST